ZA200508155B - Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "cest" applications - Google Patents
Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "cest" applications Download PDFInfo
- Publication number
- ZA200508155B ZA200508155B ZA200508155A ZA200508155A ZA200508155B ZA 200508155 B ZA200508155 B ZA 200508155B ZA 200508155 A ZA200508155 A ZA 200508155A ZA 200508155 A ZA200508155 A ZA 200508155A ZA 200508155 B ZA200508155 B ZA 200508155B
- Authority
- ZA
- South Africa
- Prior art keywords
- iii
- cest
- paramagnetic
- use according
- substrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Cephalosporin Compounds (AREA)
- Compounds Of Iron (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03008456A EP1466629A1 (en) | 2003-04-11 | 2003-04-11 | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200508155B true ZA200508155B (en) | 2007-01-31 |
Family
ID=32865006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200508155A ZA200508155B (en) | 2003-04-11 | 2004-04-06 | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "cest" applications |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8945512B2 (https=) |
| EP (3) | EP1466629A1 (https=) |
| JP (1) | JP4891763B2 (https=) |
| CN (1) | CN100579583C (https=) |
| AT (1) | ATE444763T1 (https=) |
| AU (1) | AU2004228932B2 (https=) |
| DE (1) | DE602004023492D1 (https=) |
| WO (1) | WO2004089424A1 (https=) |
| ZA (1) | ZA200508155B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008513533A (ja) * | 2004-09-23 | 2008-05-01 | ゲルベ | Cestイメージング用の造影剤封入システム |
| WO2006086343A2 (en) * | 2005-02-07 | 2006-08-17 | The Johns Hopkins University | Chemical exchange saturation transfer based mri using reporter genes and mri methods related thereto |
| JP5638752B2 (ja) * | 2005-04-26 | 2014-12-10 | コーニンクレッカ フィリップス エヌ ヴェ | Cest活性な常磁性の錯体を含むmri造影剤 |
| EP1716870A1 (en) * | 2005-04-29 | 2006-11-02 | Bracco Imaging S.p.A. | MRI contrast agents endowed with concentration independent responsiveness |
| EP1907873B1 (en) * | 2005-07-21 | 2015-02-25 | Johns Hopkins University | Non-invasive mri measurement of tissue glycogen |
| DE102007039899B3 (de) * | 2007-08-23 | 2009-04-09 | Siemens Ag | Sensor zum Ermöglichen des Nachweises einer Substanz im Körper eines Lebewesens |
| WO2011075476A1 (en) * | 2009-12-14 | 2011-06-23 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Methods and compositions relating to reporter gels for use in mri techniques |
| EP2457594A1 (en) * | 2010-11-05 | 2012-05-30 | Bracco Imaging S.p.A | Cest systems exhibiting a concentration independent responsiveness |
| CN109963839A (zh) * | 2016-09-19 | 2019-07-02 | 香港理工大学 | 手性轮环藤宁化合物及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
| US5050609B1 (en) | 1987-10-04 | 1999-11-02 | Us Health | Magnetization transfer contrast and proton relaxation and use thereof in magnetic resonance imaging |
| JPH04501723A (ja) * | 1988-11-09 | 1992-03-26 | アンガー,エヴァン,シー. | リポソーム性放射線造影剤 |
| JP2774378B2 (ja) * | 1991-02-08 | 1998-07-09 | ダイアテク,インコーポレイテッド | 映像用テクネチウム−99m標識化ポリペプチド |
| JP2894879B2 (ja) * | 1991-10-04 | 1999-05-24 | 日本メジフィジックス株式会社 | 診断用造影剤 |
| GB9420390D0 (en) * | 1994-10-10 | 1994-11-23 | Nycomed Salutar Inc | Liposomal agents |
| US5707605A (en) * | 1995-06-02 | 1998-01-13 | Research Corporation Technologies | Magnetic resonance imaging agents for the detection of physiological agents |
| JP2002512942A (ja) * | 1998-04-28 | 2002-05-08 | ヤーゴウテック アーゲー | ヒアルロナン系像形成剤 |
| EP1178837A2 (en) * | 1999-04-21 | 2002-02-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method for enhancing contrast produced by mri |
| CA2322344A1 (en) * | 1999-12-08 | 2001-06-08 | Mallinckrodt Inc. | Non-covalent bioconjugates useful for magnetic resonance imaging |
| EP1406669A2 (en) * | 2000-10-31 | 2004-04-14 | Bracco International B.V. | Conjugates of an antioxidants with metal chelating ligands |
| WO2002043775A2 (en) * | 2000-11-20 | 2002-06-06 | GODFREY, Cullen, M. | Paramagnetic metal ion-based macrocyclic contrast agents |
| DE10135355C1 (de) * | 2001-07-20 | 2003-04-17 | Schering Ag | Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie |
| EP1331012A1 (en) * | 2002-01-29 | 2003-07-30 | BRACCO IMAGING S.p.A. | Responsive paramagnetic MRI contrast agents |
-
2003
- 2003-04-11 EP EP03008456A patent/EP1466629A1/en not_active Withdrawn
-
2004
- 2004-04-06 AT AT04725938T patent/ATE444763T1/de not_active IP Right Cessation
- 2004-04-06 DE DE602004023492T patent/DE602004023492D1/de not_active Expired - Lifetime
- 2004-04-06 EP EP09155670A patent/EP2116267A1/en not_active Withdrawn
- 2004-04-06 WO PCT/EP2004/003684 patent/WO2004089424A1/en not_active Ceased
- 2004-04-06 EP EP04725938A patent/EP1613358B1/en not_active Expired - Lifetime
- 2004-04-06 JP JP2006505027A patent/JP4891763B2/ja not_active Expired - Fee Related
- 2004-04-06 US US10/552,851 patent/US8945512B2/en not_active Expired - Fee Related
- 2004-04-06 AU AU2004228932A patent/AU2004228932B2/en not_active Ceased
- 2004-04-06 ZA ZA200508155A patent/ZA200508155B/en unknown
- 2004-04-06 CN CN200480009565.0A patent/CN100579583C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2116267A1 (en) | 2009-11-11 |
| EP1466629A1 (en) | 2004-10-13 |
| US20070036727A1 (en) | 2007-02-15 |
| WO2004089424A1 (en) | 2004-10-21 |
| EP1613358A1 (en) | 2006-01-11 |
| AU2004228932A1 (en) | 2004-10-21 |
| DE602004023492D1 (de) | 2009-11-19 |
| AU2004228932B2 (en) | 2009-11-05 |
| JP4891763B2 (ja) | 2012-03-07 |
| EP1613358B1 (en) | 2009-10-07 |
| AU2004228932A2 (en) | 2004-10-21 |
| CN100579583C (zh) | 2010-01-13 |
| US8945512B2 (en) | 2015-02-03 |
| CN1809386A (zh) | 2006-07-26 |
| JP2006522761A (ja) | 2006-10-05 |
| ATE444763T1 (de) | 2009-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jacques et al. | New classes of MRI contrast agents | |
| US8318134B2 (en) | Responsive paramagnetic MRI contrast agents | |
| EP1881852B1 (en) | Mri contrast agents comprising cest active paramagnetic complex | |
| EP3334464B1 (en) | Manganese-based chelate conjugates for molecular mr imaging | |
| CA2223456A1 (en) | Chelating polymers as contrast agents for medical imaging | |
| JP2007008954A (ja) | ペプチド凝集体 | |
| AU2004228932B2 (en) | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications | |
| Querol et al. | Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs) | |
| Lerouge et al. | Towards thrombosis-targeted zeolite nanoparticles for laser-polarized 129 Xe MRI | |
| Milne et al. | Water-soluble gold nanoparticles (AuNP) functionalized with a gadolinium (III) chelate via Michael addition for use as a MRI contrast agent | |
| Pushparaj et al. | Trinuclear Gd (III) metal complex with amide core display remarkable enhancement in relaxivity | |
| EP1879625B1 (en) | Mri contrast agents endowed with concentration independent responsiveness | |
| Laurent et al. | Paramagnetic gadolinium complexes | |
| Pushparaj et al. | Development of novel dinuclear [Gd (III) DO3VA] complexes decorated with isovaleric acid as MRI contrast agents for tumor diagnosis | |
| EP1106186A2 (en) | Non-covalent bioconjugates useful for magnetic resonance imaging | |
| Pushparaj et al. | Synthesis and relaxivity measurements of novel Gd (III) complex of DOTVA as MRA contrast agents | |
| Angelovski | Magnetic Resonance Imaging Bio-Sensors for Calcium (II) | |
| D. Moore et al. | Multilanthanide systems for medical imaging applications | |
| Geraldes | Paramagnetic NMR effects of lanthanide ions as structural reporters of supramolecular complexes | |
| Chowdhury et al. | Encapsulated or amphiphilic liposomal Fe (III) coordination complexes for MRI studies of tumor uptake and clearance | |
| Laurent et al. | Noncovalent Binding of Some New Lipophilic Gadolinium DTPA Complexes to Human Serum Albumin. A Structure–Affinity Relationship | |
| Sowers | Advancements in branched bottlebrush polymers for responsive, targeted imaging | |
| Giardiello | High relaxivity contrast agents for magnetic resonance imaging (MRI) |